Feline Reactive (AA) Amyloidosis

Overview

While the hereditary form of renal amyloidosis in predisposed breeds is covered in its own entry, this addresses the distinct, secondary form occurring as a consequence of chronic inflammation elsewhere in the body — a genuinely different underlying mechanism producing a similar end result of amyloid deposits affecting kidney function.

Symptoms

• Increased thirst/urination (moderate, uncommon)
• Decreased appetite (moderate, uncommon)

Causes

Develops as a consequence of chronic, longstanding inflammation elsewhere in the body (such as chronic infection or certain long-term inflammatory conditions), which drives sustained production of a specific inflammatory protein that can, over time, deposit abnormally within the kidneys and other organs as amyloid material — this represents a genuinely different underlying mechanism than the hereditary form seen in predisposed breeds. Distinct from the breed-associated (often called familial) amyloidosis pattern, reactive or AA amyloidosis develops secondary to a chronic inflammatory or infectious condition elsewhere in the body, with prolonged inflammation triggering abnormal amyloid protein production that then deposits in the kidneys and sometimes other organs.

Risk Factors

Any chronic, longstanding inflammatory condition elsewhere in the body is the primary risk factor for this specific secondary form.

Transmission

Not directly contagious; reflects a consequence of chronic inflammation rather than something transmitted, though an underlying infectious inflammatory trigger would have its own transmission considerations.

Incubation Period

Develops gradually over the course of chronic, longstanding inflammation, often over months to years.

Disease Stages & Progression

Sustained chronic inflammation drives ongoing production of the relevant inflammatory protein, which over time can deposit as amyloid material within the kidneys, progressively impairing normal function similar in end result to the hereditary form, though this represents a genuinely different underlying disease process requiring different management considerations.

Early Warning Signs

Symptoms similar to chronic kidney disease generally, occurring in a cat with a known history of chronic inflammatory disease.

Advanced Symptoms

Progressive kidney dysfunction symptoms as amyloid accumulation continues.

Diagnostic Methods

Kidney biopsy showing the characteristic amyloid deposits, combined with identifying an underlying chronic inflammatory trigger, distinguishes this secondary form from the hereditary type.

Veterinary Examination Process

Assessment of kidney disease symptoms alongside investigation for any underlying chronic inflammatory condition.

Recommended Lab Tests

Kidney function panel, biopsy for definitive diagnosis, and investigation for underlying inflammatory triggers.

Diagnostic Imaging

Ultrasound may show kidney changes, though these aren't specific enough alone to confirm this particular cause.

Blood Test Indicators

Kidney function tests show progressive dysfunction; investigation for an underlying chronic inflammatory condition is genuinely important.

Biopsy / Histopathology

Essential for definitive diagnosis, showing the characteristic amyloid deposits; specific staining techniques can sometimes help distinguish this secondary form from the hereditary type.

Differential Diagnoses

The hereditary form of renal amyloidosis, and standard chronic kidney disease — biopsy combined with investigation for an underlying chronic inflammatory trigger helps distinguish this specific secondary form.

Home Monitoring Guidance

Not a substitute for veterinary evaluation of kidney disease symptoms, particularly in a cat with known chronic inflammatory disease.

Veterinary Treatment Options

Identifying and treating any underlying chronic inflammatory condition is genuinely important, since addressing this root driver may help slow further amyloid accumulation; supportive kidney-focused management follows similar general principles to chronic kidney disease broadly. Identifying and treating the underlying chronic inflammatory or infectious trigger is an important part of management, alongside supportive care for the kidney effects the amyloid deposition has already caused.

Surgery Requirements

Not applicable to the kidney condition itself.

Recovery Timeline

Not applicable — a progressive condition managed rather than cured, though addressing the underlying inflammatory trigger may help slow progression.

Possible Complications

Progressive kidney dysfunction, similar to chronic kidney disease generally.

Long-Term Management

Ongoing management of any underlying chronic inflammatory condition alongside kidney-focused supportive care.

Prevention

Prompt, appropriate treatment of chronic inflammatory conditions may help reduce this specific complication's risk by limiting the sustained inflammatory drive that leads to amyloid formation.

Vaccination Availability

Not applicable.

Prognosis

Variable and dependent on both the kidney involvement and how effectively any underlying chronic inflammatory condition can be addressed.

References

American College of Veterinary Internal Medicine (ACVIM); veterinary nephrology references.

Medications Used

• Treatment for any identified underlying chronic inflammatory condition
• Supportive chronic kidney disease management medications

Estimated Treatment Cost by Country

Frequently Asked Questions